Scienture Holdings, Inc. (SCNX): Revenue
$431.6K
Year ended 2025-12-31
$821.3K
Trailing 12 months to 2026-06-30
-65.2%
3-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $431.6K | +215.9% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $136.6K | -90.0% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $1.36M | -86.7% | 2025-03-26, From 2023-01-01 |
| 2022-12-31 | $10.25M | n/c | 2024-04-22, From 2022-01-01 |
| 2021-12-31 | $9.89M | -42.2% | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | $17.12M | +130.3% | 2022-03-28, From 2020-01-01 |
| 2019-12-31 | $7.44M | +94.1% | 2021-03-29, From 2019-01-01 |
| 2018-12-31 | $3.83M | +30.7% | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | $2.93M | +18.1% | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | $2.48M | -14.8% | 2017-03-30, From 2016-01-01 |
| 2015-12-31 | $2.91M | n/c | 2017-03-30, From 2015-01-01 |
| 2014-12-31 | $1.50M | +56.5% | 2016-03-28, From 2014-01-01 |
| 2013-12-31 | $955.9K | n/a | 2015-03-23, From 2013-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $431.6K | +215.9% |
| Medicinova Inc (MNOV) | 2025-12-31 | $409.7K | n/a |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $405.0K | -39.9% |
| America Great Health (AAGH) | 2025-06-30 | $391.7K | +32.9% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $500.0K | n/a |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $536.4K | +19.3% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $537.1K | -39.9% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $336.1K | -45.5% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $559.0K | -98.7% |
Compare SCNX, MNOV, CANF, AAGH side by side · Screen every company in Pharmaceutical Preparations ↗